Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseases.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Acta Neurobiologiae Experimentalis

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 15190675
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic aspects of Alzheimer's disease.

  2004cited by this paper
• Thiothalidomides: novel isosteric analogues of thalidomide with enhanced TNF-alpha inhibitory activity.

  2003cited by this paper
• New insights into the pharmacological and toxicological effects of thalidomide.

  2003cited by this paper
• A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease.

  2003cited by this paper
• Role of cytokines in the gene expression of amyloid β–protein precursor: Identification of a 5'-UTR-Binding nuclear factor and its implications in Alzheimer's disease

  2003cited by this paper
• Thalidomide as an anti‐cancer agent

  2002cited by this paper
• Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer’s disease

  2002cited by this paper
• Transforming growth factor-β-induced transcription of the Alzheimer β-amyloid precursor protein gene involves interaction between the CTCF-complex and Smads

  2002cited by this paper
• Transforming growth factor-beta-induced transcription of the Alzheimer beta-amyloid precursor protein gene involves interaction between the CTCF-complex and Smads.

  2002cited by this paper
• 5´-OH-Thalidomide, a Metabolite of Thalidomide, Inhibits Angiogenesis

  2002cited by this paper
• Current drug targets for Alzheimer's disease treatment

  2002cited by this paper
• An Iron-responsive Element Type II in the 5′-Untranslated Region of the Alzheimer's Amyloid Precursor Protein Transcript*

  2002cited by this paper
• Alzheimer’s disease drug discovery targeted to the APP mRNA 5′Untranslated region

  2002cited by this paper
• Thalidomide: emerging role in cancer medicine.

  2002cited by this paper
• Thalidomide and its analogues inhibit lipopolysaccharide-mediated Iinduction of cyclooxygenase-2.

  2001cited by this paper
• Inflammation and Alzheimer disease: The good, the bad, and the ugly

  2001cited by this paper
• The 3′ Untranslated Region of Tumor Necrosis Factor Alpha mRNA Is a Target of the mRNA-Stabilizing Factor HuR

  2001cited by this paper
• Phenserine regulates translation of β-amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development

  2001cited by this paper
• Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence.

  2001cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins

  2001cited by this paper
• Versatile Role for hnRNP D Isoforms in the Differential Regulation of Cytoplasmic mRNA Turnover

  2001cited by this paper
• Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease.

  2001cited by this paper
• Structural Remodeling of an A + U-rich RNA Element by Cation or AUF1 Binding*

  2001cited by this paper
• Interleukin-1, neuroinflammation, and Alzheimer's disease.

  2001cited by this paper
• HuR and mRNA stability

  2001cited by this paper
• Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease.

  2001cited by this paper
• Inflammation, autotoxicity and Alzheimer disease.

  2001cited by this paper
• Neuroinflammation and Alzheimer's disease: Critical roles for cytokine/Aβ-induced glial activation, NF-κB, and apolipoprotein E

  2000cited by this paper
• Electrophoretic mobility shift assay for the detection of specific DNA-protein complex in nuclear extracts from the cultured cells and frozen autopsy human brain tissue.

  2000cited by this paper
• Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA.

  2000cited by this paper
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• Neuroinflammation and Alzheimer's disease: critical roles for cytokine/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E.

  2000cited by this paper
• ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system.

  1999cited by this paper
• Evidence that Tristetraprolin Binds to AU-Rich Elements and Promotes the Deadenylation and Destabilization of Tumor Necrosis Factor Alpha mRNA

  1999cited by this paper
• Identification of AUF-1 ligands reveals vast diversity of early response gene mRNAs.

  1999cited by this paper
• Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies.

  1999cited by this paper
• Translation of the Alzheimer Amyloid Precursor Protein mRNA Is Up-regulated by Interleukin-1 through 5′-Untranslated Region Sequences*

  1999cited by this paper
• Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin.

  1998cited by this paper
• Feedback Inhibition of Macrophage Tumor Necrosis Factor-α Production by Tristetraprolin

  1998cited by this paper
• Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent.

  1998cited by this paper
• Thalidomide Costimulates Primary Human T Lymphocytes, Preferentially Inducing Proliferation, Cytokine Production, and Cytotoxic Responses in the CD8+ Subset

  1998cited by this paper
• Smads: transcriptional activators of TGF-beta responses.

  1998cited by this paper
• Overexpression of HuR, a nuclear–cytoplasmic shuttling protein, increases the in vivo stability of ARE‐containing mRNAs

  1998cited by this paper
• Astrocytes containing amyloid beta-protein (Abeta)-positive granules are associated with Abeta40-positive diffuse plaques in the aged human brain.

  1998cited by this paper
• Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay

  1997cited by this paper
• Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal.

  1996cited by this paper
• NF-kappa B: a lesson in family values.

  1995cited by this paper
• Promoter activity of the gene encoding the beta-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid and interleukin-1.

  1995cited by this paper
• Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1.

  1995cited by this paper
• AU-rich elements: characterization and importance in mRNA degradation.

  1995cited by this paper
• Translational control of cytokine expression by 3' UA-rich sequences.

  1994cited by this paper
• Thalidomide is an inhibitor of angiogenesis.

  1994cited by this paper
• The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum.

  1993cited by this paper
• Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

  1993cited by this paper
• Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors.

  1992cited by this paper
• Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor.

  1992cited by this paper
• Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

  1991cited by this paper
• Synthesis, central nervous system activity and teratogenicity of a homothalidomide.

  1990cited by this paper
• Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level [published erratum appears in J Exp Med 1990 Mar 1;171(3):971-2]

  1990cited by this paper
• Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells.

  1989cited by this paper
• Translational blockade imposed by cytokine-derived UA-rich sequences.

  1989cited by this paper
• Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

  1989cited by this paper
• Thionation reactions of lawesson's reagents

  1985cited by this paper
• Thalidomide in the treatment of lepra reactions

  1965cited by this paper

• Design and synthetic approaches to thalidomide based small molecule degraders.

  2025cites this paper
• A mechanistic perspective, clinical applications, and phage-display-assisted discovery of TNFα inhibitors.

  2021cites this paper
• 3,6’-Dithiothalidomide Reduces Tinnitus Phenotype in Two Different Mouse Preclinical Models of Tinnitus

  2020cites this paper
• Current and Prospective Treatments for Alzheimer's Disease (and Other Neurodegenerative Diseases)

  2019cites this paper
• Post-Injury Neuroprotective Effects of the Thalidomide Analog 3,6′-Dithiothalidomide on Traumatic Brain Injury

  2019cites this paper
• Neurodegenerative disease treatments by direct TNF reduction, SB623 cells, maraviroc and irisin and MCC950, from an inflammatory perspective – a Commentary

  2019cites this paper
• Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments

  2019cites this paper
• Tumor necrosis factor-α levels and non-surgical bleeding in continuous-flow left ventricular assist devices.

  2018cites this paper
• A new Alzheimer's disease cell model using B cells to induce beta amyloid plaque formation and increase TNF alpha expression

  2018cites this paper
• Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses.

  2017cites this paper
• Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's Disease: Results from a Double-Blind, Placebo-Controlled Trial.

  2017cites this paper
• Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents

  2016cites this paper
• Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.

  2016cites this paper
• Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimer’s Disease

  2016cites this paper
• Therapeutic strategies for Alzheimer’s disease in clinical trials

  2016cites this paper
• Novel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development.

  2016cites this paper
• Tumor necrosis factor‐α potentiates long‐term potentiation in the rat dentate gyrus after acute hypoxia

  2015cites this paper
• Differentiation of antiinflammatory and antitumorigenic properties of stabilized enantiomers of thalidomide analogs

  2015influential citation
• Treatment implications of the altered cytokine-insulin axis in neurodegenerative disease.

  2013cites this paper
• Pomalidomide is nonteratogenic in chicken and zebrafish embryos and nonneurotoxic in vitro

  2013cites this paper
• 3,6′‐dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation

  2013cites this paper
• TNF α signaling beholds thalidomide saga: a review of mechanistic role of TNF-α signaling under thalidomide.

  2012cites this paper
• 3,6′‐Dithiothalidomide, a new TNF‐α synthesis inhibitor, attenuates the effect of Aβ1–42 intracerebroventricular injection on hippocampal neurogenesis and memory deficit

  2012cites this paper
• TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation

  2012cites this paper
• Beyond amyloid: the future of therapeutics for Alzheimer's disease.

  2012cites this paper
• Tumor necrosis factor-alpha synthesis inhibitor 3,6' -dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease

  2012cites this paper
• Tumor Necrosis Factor-Induced Cerebral Insulin Resistance in Alzheimer's Disease Links Numerous Treatment Rationales

  2012cites this paper
• Early intervention with a small molecule inhibitor for tumor nefosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer’s disease

  2012cites this paper
• Tumor necrosis factor-α synthesis inhibitor 3,6′-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s disease

  2012cites this paper
• Tumor necrosis factor‐α synthesis inhibitor, 3,6′‐dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice

  2011cites this paper
• Targeting TNF-Alpha to Elucidate and Ameliorate Neuroinflammation in Neurodegenerative Diseases

  2011cites this paper
• Why Do Temporal Generalization Gradients Change When People Make Decisions as Quickly as Possible?

  2011cites this paper
• Thalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of Inflammation

  2011cites this paper
• Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.

  2011cites this paper
• Role of Inflammation in Infectious Disease

  2011cites this paper
• Effects of thalidomide and pentoxyphylline over local and remote organ injury after intestinal ischemia/reperfusion.

  2010cites this paper
• Effects of Thalidomide and Pentoxyphylline Over Local and Remote Organ Injury After Intestinal Ischemia/Reperfusion

  2010cites this paper
• A Review of Methods to Monitor the Modulation of mRNA Stability

  2010cites this paper
• The roles of TNF in brain dysfunction and disease.

  2010cites this paper
• Thalidomide fails to be therapeutic following contusive spinal cord injury in rats.

  2009cites this paper
• Accelerated Prion Disease Pathogenesis in Toll-Like Receptor 4 Signaling-Mutant Mice

  2008cites this paper
• Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta-induced impairment of recognition memory in mice.

  2008cites this paper
• TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets.

  2007cites this paper
• Treatment of Cachexia in the Elderly

  2006cites this paper
• Cardiovascular Disease Could Be Contained Based on Currently Available Data!

  2006cites this paper
• New Therapeutic Strategies and Drug Candidates for Neurodegenerative Diseases: p53 and TNF‐α Inhibitors, and GLP‐1 Receptor Agonists

  2004cites this paper
• New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists.

  2004cites this paper